Target intelligence / Profile preview

Methanogenic archaeal surface layer protein (SLP)

Target
SLP
Molecular classification
Structural protein, Glycoprotein
01

Overview

The methanogenic archaeal surface layer (S-layer) protein is the primary structural component of the cell envelope in methane-producing archaea, such as Methanobrevibacter smithii (Sleytr et al., 2014, PMID: 24504150). These proteins self-assemble into a symmetric, porous monomolecular lattice that provides mechanical stability, determines cell shape, and acts as a protective barrier against environmental stressors (Albers & Meyer, 2011, PMID: 21304546). In the human microbiome, methanogens are increasingly recognized for their role in metabolic and gastrointestinal disorders, where they consume hydrogen to produce methane, potentially slowing intestinal transit and altering energy harvest (Gaci et al., 2014, PMID: 24833331). High levels of these organisms are specifically associated with constipation-predominant irritable bowel syndrome (IBS-C) and obesity (Mathur et al., 2013, PMID: 23533578). While most current treatments for methanogen overgrowth, such as lovastatin, target metabolic enzymes like HMG-CoA reductase, the S-layer represents a critical structural vulnerability for maintaining cell integrity (Gottlieb et al., 2016, PMID: 26854112). The S-layer also serves as an interface for host-pathogen interactions and can influence the host immune response (Pum et al., 2013, PMID: 23735445). Targeting the S-layer or its assembly process could provide a highly specific means of modulating methanogen populations without affecting beneficial bacterial species. Furthermore, the unique properties of these proteins are being explored for biotechnological applications, including drug delivery systems and vaccine scaffolds (Sleytr et al., 2014, PMID: 24504150).

Other names
S-layer proteinSLPArchaeal surface layerMethanogen cell wall proteinSurface layer protein
02

Mechanism of action

Inhibition of methanogen growth and methane production through structural disruption or metabolic interference.

03

Biological functions

Cell wall assemblyCell shape maintenanceMolecular sievingEnvironmental protectionCell adhesion
04

Disease associations

Irritable bowel syndromeObesityPeriodontitisSmall intestinal bacterial overgrowth
05

Safety considerations

Alteration of gut microbiota diversityPotential for systemic absorption of non-absorbable antibiotics
06

Interacting drugs

Lovastatin

3 more in the full profile.

07

Biomarkers

Breath methane concentrationMethanobrevibacter smithii abundance in stool

Beyond the preview

Go deeper on Methanogenic archaeal surface layer protein (SLP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methanogenic archaeal surface layer protein (SLP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call